UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3396-3403

2005

Volltextzugriff (PDF)

OP66 First line therapy with fludarabine, cyclophosphamide and rituximab for CLL

Leukemia research, 2007, Vol.31, p.S62-S63

Keating, M.J

2007

Volltextzugriff (PDF)

E14 Therapy for CLL: current approach, future trends

Leukemia research, 2007, Vol.31, p.S25-S26

Keating, M.J

2007

Volltextzugriff (PDF)

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

Leukemia, 2015-09, Vol.29 (9), p.1811-1822

2015

Volltextzugriff (PDF)

Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation

Leukemia, 2015-04, Vol.29 (4), p.783-787

2015

Volltextzugriff (PDF)

PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia

Value in health, 2012-06, Vol.15 (4), p.A226-A226

2012

Volltextzugriff (PDF)

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

Leukemia, 2012-07, Vol.26 (7), p.1576-1583

2012

Volltextzugriff (PDF)

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

Annals of oncology, 2016-06, Vol.27 (6), p.1100-1106

2016

Volltextzugriff (PDF)

Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes

Leukemia, 2016-08, Vol.30 (8), p.1803-1804

2016

Volltextzugriff (PDF)

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP

Leukemia, 2010-05, Vol.24 (5), p.1096-1098

2010

Volltextzugriff (PDF)

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

Leukemia, 2008-06, Vol.22 (6), p.1191-1199

2008

Volltextzugriff (PDF)

Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

Leukemia, 2012-08, Vol.26 (8), p.1812-1820

2012

Volltextzugriff (PDF)

OP68 Gene therapy for patients with CLL

Leukemia research, 2007, Vol.31, p.S63-S64

2007

Volltextzugriff (PDF)

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Leukemia, 2016-02, Vol.30 (2), p.325-330

2016

Volltextzugriff (PDF)

Trisomy 12 CLLs progress through NOTCH1 mutations

Leukemia, 2013-03, Vol.27 (3), p.740-743

2013

Volltextzugriff (PDF)

The phosphoinositide-3-kinase , overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

Leukemia, 2015-09, Vol.29 (9), p.1811

2015

Volltextzugriff (PDF)

249 ORAL Specific activation of microRNA 106b targets the ubiquitin ligase ITCH to enable the p73 apoptotic response in chronic lymphocytic leukemia

European journal of cancer supplements, 2008, Vol.6 (12), p.82-82

2008

Volltextzugriff (PDF)

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

Blood, 1998-08, Vol.92 (4), p.1165-1171

1998

Volltextzugriff (PDF)

Results of First Salvage Therapy for Patients Refractory to a Fludarabine Regimen in Chronic Lymphocytic Leukemia

Leukemia & lymphoma, 2002, Vol.43 (9), p.1755-1762

2002

Volltextzugriff (PDF)

Loss of p53 and altered miR15-a/16-1 → MCL-1 pathway in CLL: insights from TCL1-Tg:[p53.sup.-/-] mouse model and primary human leukemia cells

Leukemia, 2014-01, Vol.28 (1), p.118

2014

Volltextzugriff (PDF)

A topographic representation of auditory space in the external nucleus of the inferior colliculus of the guinea-pig

Brain research, 1992-09, Vol.589 (2), p.231-242

1992

Volltextzugriff (PDF)

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Leukemia, 2002-06, Vol.16 (6), p.1045-1052

2002

Volltextzugriff (PDF)

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation

Cytotherapy (Oxford, England), 2002-05, Vol.4 (3), p.217-221

2002

Volltextzugriff (PDF)

Generation Of CLL-Specific CTL Effectors From Partially HLA-Matched Umbilical Cord Blood Grafts Using CD154-Transduced CLL Cell S As APCs

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.123-123

2009

Volltextzugriff (PDF)

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine

Annals of oncology, 2001-05, Vol.12 (5), p.621-625

2001

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(61)
Biological And Medical Sciences
(33)
Humans
(33)
Female
(25)
Animals
(24)
Male
(20)
Medical Sciences
(19)
Neurosciences & Neurology
(18)
Aged
(17)
Hematology
(17)
Middle Aged
(17)
Neurosciences
(17)
Oncology
(17)
Chronic Lymphocytic Leukemia
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Leukemia
(12)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(12)
Adult
(11)
Genetic Aspects
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(13)
Brain Research
(6)
Leukemia Research
(6)
Annals Of Oncology
(5)
Blood
(5)
Field Crops Research
(5)
Journal Of Dairy Science
(4)
Neuroscience
(4)
Neuroscience Letters
(4)
Brain Research. Developmental Brain Research
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

OP66 First line therapy with fludarabine, cyclophosphamide and rituximab for CLL

E14 Therapy for CLL: current approach, future trends

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation

PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

OP68 Gene therapy for patients with CLL

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Trisomy 12 CLLs progress through NOTCH1 mutations

The phosphoinositide-3-kinase , overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

249 ORAL Specific activation of microRNA 106b targets the ubiquitin ligase ITCH to enable the p73 apoptotic response in chronic lymphocytic leukemia

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

Results of First Salvage Therapy for Patients Refractory to a Fludarabine Regimen in Chronic Lymphocytic Leukemia

Loss of p53 and altered miR15-a/16-1 → MCL-1 pathway in CLL: insights from TCL1-Tg:[p53.sup.-/-] mouse model and primary human leukemia cells

A topographic representation of auditory space in the external nucleus of the inferior colliculus of the guinea-pig

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation

Generation Of CLL-Specific CTL Effectors From Partially HLA-Matched Umbilical Cord Blood Grafts Using CD154-Transduced CLL Cell S As APCs

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine

Suchergebnisse filtern